Greenwich LifeSciences GLSI
NASDAQ GLSI
$16.09 +0.02 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Greenwich LifeSciences (GLSI) Accumulated Expenses (2020 - 2026)

Updated

Greenwich LifeSciences (GLSI) recorded Accumulated Expenses of $220,845 in Q2 2024, unchanged from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Accumulated Expenses (2020 - 2026) Analysis & Trends

Starting with Q3 2020, Greenwich LifeSciences' Accumulated Expenses history includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Greenwich LifeSciences 235.88 Mn 206.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220,845.00
Mar 31, 2026 220,845.00
Dec 31, 2025 220,845.00
Sep 30, 2024 220,845.00
Jun 30, 2024 220,845.00
Mar 31, 2024 220,845.00
Dec 31, 2023 220,845.00
Sep 30, 2020 42,580.00
API Access

Greenwich LifeSciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=GLSI&period=max&api_key=YOUR_API_KEY